GO:1903551 regulation of extracellular exosome assembly: Vesicle Biogenesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903551 describes any process that modulates the frequency, rate or extent of extracellular vesicular exosome assembly, a key step in intercellular communication.
• Exosomes are small extracellular vesicles of endosomal origin that carry proteins, lipids, and nucleic acids to recipient cells, influencing cancer, immunity, and tissue repair.
• Regulation of exosome assembly involves endosomal sorting complexes required for transport (ESCRT) and accessory proteins, and is fine-tuned by signaling pathways such as Snail and VEGFR2.
• Dysregulated exosome assembly contributes to cisplatin resistance in cancer, stress granule assembly in triple-negative breast cancer, and vascular inflammation.
• Emerging evidence links exosome biology to polycystic kidney disease and preeclampsia, highlighting its broad physiological relevance.
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect the causal roles of genes regulating exosome assembly.
Description
Extracellular exosomes are nanometer-sized vesicles released by cells and are central to intercellular communication, transferring proteins, lipids, and RNA between cells. The process by which these vesicles are assembled is tightly regulated, and the Gene Ontology term GO:1903551, regulation of extracellular exosome assembly, captures any process that modulates the frequency, rate or extent of this assembly. Understanding this regulation is critical because exosomes influence diverse biological processes, from immune responses to tumor progression. Recent studies have identified specific regulators, such as Snail, which controls exosomal microRNA-21 to suppress NLRP3 inflammasome activity and enhance cisplatin resistance. Similarly, circRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in triple-negative breast cancer, indirectly affecting exosome-related pathways. These findings underscore the importance of exosome assembly regulation in disease mechanisms and therapeutic resistance.
regulation of extracellular exosome assembly At A Glance
| GO ID | GO:1903551 |
|---|---|
| GO term | regulation of extracellular exosome assembly |
| Ontology | biological_process |
| Synonym | regulation of extracellular vesicular exosome assembly |
| Major function | Modulates the frequency, rate or extent of exosome assembly, impacting intercellular communication |
| Related processes | Exosome biogenesis, endosomal sorting, vesicle transport |
| Key regulators | Snail, VEGFR2, CD151, circRNA-CREIT, and ESCRT components |
| Disease relevance | Cancer chemoresistance, vascular inflammation, polycystic kidney disease, preeclampsia |
What Is GO:1903551?
GO:1903551, regulation of extracellular exosome assembly, is defined as any process that modulates the frequency, rate or extent of extracellular vesicular exosome assembly. This biological process encompasses the molecular events that control the formation of exosomes, which are small vesicles of endosomal origin released into the extracellular space. Regulation can occur at multiple steps, including cargo sorting, membrane budding, and vesicle release, and involves a network of proteins and signaling pathways.
Why Is regulation of extracellular exosome assembly Important in Cell Biology?
Regulation of extracellular exosome assembly is fundamental to intercellular communication and has profound implications for human health and disease. Exosomes carry bioactive molecules that can reprogram recipient cells, influencing processes such as immune evasion, metastasis, and tissue repair. Dysregulation of exosome assembly is linked to cancer drug resistance, as shown by Snail-regulated exosomal microRNA-21 enhancing cisplatin resistance, and to stress granule assembly in triple-negative breast cancer. Moreover, proteins like CD151 maintain endolysosomal protein quality to inhibit vascular inflammation, highlighting the intersection of exosome regulation with vascular biology. Understanding this process offers opportunities for biomarker discovery and therapeutic intervention.
• Exosomes mediate intercellular communication by transferring proteins, lipids, and RNA.
• Regulation of exosome assembly affects cancer chemoresistance, including cisplatin and doxorubicin resistance.
• Exosome assembly is linked to vascular inflammation through proteins such as CD151.
• Dysregulated exosome assembly may contribute to polycystic kidney disease pathogenesis.
• VEGFR2-associated proteins in placentas connect exosome regulation to preeclampsia and diabetes.
• Exosome-based therapies are emerging for wound healing and chronic wound management.
• Exosomes are potential biomarkers for disease diagnosis and prognosis.
• Targeting exosome assembly regulators could overcome drug resistance in cancers.
• Exosome assembly intersects with stress granule formation, impacting RNA metabolism.
• CRISPR screening can identify novel regulators of exosome assembly for therapeutic development.
What Happens During regulation of extracellular exosome assembly?
Initiation of exosome biogenesis
In simple terms: The cell starts making tiny bubbles inside itself that will later be released.
Exosome assembly begins with the inward budding of the endosomal membrane, forming intraluminal vesicles (ILVs) within multivesicular bodies (MVBs). This process is regulated by the endosomal sorting complex required for transport (ESCRT) machinery and accessory proteins. Regulation of this step determines the rate and cargo composition of exosomes, influencing downstream intercellular communication.
Cargo sorting and regulation by signaling pathways
In simple terms: Specific molecules are selected to go into the bubbles, guided by cellular signals.
Cargo sorting into exosomes is a regulated process that selects proteins, lipids, and RNAs. Signaling pathways, such as Snail, can modulate the sorting of specific microRNAs like miR-21 into exosomes, which then affect recipient cells. CircRNA-CREIT inhibits stress granule assembly and can influence exosome cargo, thereby impacting drug resistance in triple-negative breast cancer. These examples illustrate how regulation of exosome assembly is integrated with cellular stress and signaling networks.
MVB maturation and transport
In simple terms: The bubbles are packaged into larger containers that move to the cell surface.
After ILV formation, MVBs mature and are transported along cytoskeletal tracks to the plasma membrane. Proteins such as CD151 maintain endolysosomal protein quality and influence MVB trafficking, thereby regulating exosome assembly and inhibiting vascular inflammation. VEGFR2-associated proteins in human placentas have been linked to preeclampsia and diabetes, suggesting that MVB transport regulation is relevant to pregnancy-related disorders.
Fusion and release of exosomes
In simple terms: The containers fuse with the outer membrane, releasing the bubbles outside the cell.
The final step of exosome assembly is the fusion of MVBs with the plasma membrane, releasing ILVs as exosomes into the extracellular space. This step is regulated by Rab GTPases and SNARE proteins. Dysregulation of this release can contribute to pathology, as seen in polycystic kidney disease where an extracellular vesicle-based hypothesis has been proposed. Regulation of exosome release is also critical for wound healing, where exosomes from stem cells or biomaterials promote tissue repair.
Key Genes Involved in GO:1903551 regulation of extracellular exosome assembly
The following genes and proteins have been experimentally implicated in the regulation of extracellular exosome assembly, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Snail | Regulates exosomal microRNA-21 sorting | Enhances cisplatin resistance via NLRP3 inflammasome suppression |
| VEGFR2 | Associated with placental exosome regulation | Linked to preeclampsia, diabetes, and gravidity |
| CD151 | Maintains endolysosomal protein quality | Inhibits vascular inflammation |
| CircRNA-CREIT | Inhibits stress granule assembly | Overcomes doxorubicin resistance in TNBC |
| PKR | Stress granule assembly regulator | Destabilized by circRNA-CREIT |
| NLRP3 | Inflammasome component | Suppressed by exosomal miR-21 |
| ESCRT components | Mediate ILV formation | Core machinery for exosome biogenesis |
| Rab GTPases | Regulate MVB trafficking and fusion | Control exosome release |
| SNARE proteins | Mediate MVB-plasma membrane fusion | Essential for exosome secretion |
| miR-21 | Exosomal cargo | Modulates recipient cell inflammasome |
| CD9 | Tetraspanin marker | Enriched on exosomes, used for isolation |
| CD63 | Tetraspanin marker | Enriched on exosomes, used for isolation |
| CD81 | Tetraspanin marker | Enriched on exosomes, used for isolation |
| Alix | ESCRT accessory protein | Involved in exosome biogenesis |
| TSG101 | ESCRT-I component | Required for ILV formation |
| HRS | ESCRT-0 component | Cargo sorting into exosomes |
| VPS4 | ESCRT-III associated ATPase | Regulates MVB sorting |
| Syntenin | PDZ domain protein | Links cargo to ESCRT for exosome loading |
How Is regulation of extracellular exosome assembly Regulated?
Regulation of extracellular exosome assembly is controlled by multiple signaling pathways and cellular stresses. The Snail transcription factor regulates the sorting of miR-21 into exosomes, which then suppresses NLRP3 inflammasome activity in recipient cells, enhancing cisplatin resistance. CircRNA-CREIT inhibits stress granule assembly by destabilizing PKR, thereby affecting exosome-related pathways and overcoming doxorubicin resistance in triple-negative breast cancer. CD151 maintains endolysosomal protein quality, and its loss leads to vascular inflammation, indicating that protein quality control pathways regulate exosome assembly. Additionally, VEGFR2-associated proteins in human placentas are linked to preeclampsia and diabetes, suggesting that growth factor signaling modulates exosome regulation in pregnancy. These examples highlight the integration of exosome assembly with diverse cellular regulatory networks.
regulation of extracellular exosome assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Snail | Cisplatin resistance in cancer | Knockout in cancer cell lines, exosome isolation |
| CircRNA-CREIT | Doxorubicin resistance in TNBC | Overexpression in TNBC cells, stress granule assays |
| CD151 | Vascular inflammation | Endothelial cell knockout, exosome profiling |
| VEGFR2 | Preeclampsia, diabetes | Placental trophoblast models, proteomics |
| ESCRT components | Polycystic kidney disease | Kidney organoids, knockout models |
Cancer chemoresistance
Dysregulation of exosome assembly contributes to chemoresistance in multiple cancers. Snail-regulated exosomal miR-21 suppresses NLRP3 inflammasome activity, enhancing cisplatin resistance in cancer cells. In triple-negative breast cancer, circRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance by destabilizing PKR, indirectly affecting exosome cargo and assembly. These findings suggest that targeting exosome assembly regulators could sensitize tumors to chemotherapy.
Vascular inflammation
CD151 maintains endolysosomal protein quality to inhibit vascular inflammation, and its dysfunction leads to impaired exosome assembly and increased inflammatory signaling. This links regulation of exosome assembly to endothelial cell biology and cardiovascular disease.
Polycystic kidney disease
An extracellular vesicle-based hypothesis for the genesis of polycystic kidney diseases has been proposed, suggesting that dysregulated exosome assembly and cargo contribute to cyst formation and disease progression. This highlights the importance of exosome regulation in renal pathology.
Preeclampsia and pregnancy disorders
Proteomic studies of VEGFR2 in human placentas reveal associations with preeclampsia, diabetes, gravidity, and labor, implicating exosome regulation in pregnancy-related disorders. VEGFR2 signaling may influence exosome assembly in the placenta, affecting maternal-fetal communication.
From regulation of extracellular exosome assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate exosome assembly rate? | CRISPR knockout in HEK293 or HeLa cells followed by exosome quantification |
| Does a point mutation in gene Y affect exosome cargo sorting? | CRISPR point mutation knock-in in cancer cell lines |
| Does overexpression of gene Z increase exosome release? | CRISPR knock-in of inducible promoter or lentiviral overexpression |
| Does tagged protein localize to MVBs? | CRISPR knock-in of fluorescent tag (e.g., GFP) |
| Does gene W affect exosome-mediated drug resistance? | CRISPR knockout in resistant cancer cells, drug sensitivity assays |
| Does circRNA-CREIT modulate stress granules and exosomes? | CRISPR knockout or overexpression in TNBC cells |
How to Study the regulation of extracellular exosome assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Nanoparticle tracking analysis | Size and concentration of exosomes | Quantifying exosome release after gene knockout |
| Western blot | Exosomal marker proteins (CD9, CD63, CD81) | Confirming exosome identity and purity |
| Mass spectrometry | Protein cargo and interactors | Identifying regulators of exosome assembly |
| RNA sequencing | Exosomal RNA content | Discovering sorting mechanisms |
| Fluorescence microscopy | MVB and exosome trafficking | Visualizing assembly steps |
| Electron microscopy | Ultrastructure of ILVs and MVBs | Validating exosome morphology |
| CRISPR knockout screening | Genes affecting exosome assembly | High-throughput discovery of regulators |
| Exosome transfer assays | Functional effects on recipient cells | Testing drug resistance or inflammation |
Exosome isolation and characterization
Exosomes are typically isolated from conditioned media by differential ultracentrifugation, size-exclusion chromatography, or immunocapture using tetraspanin markers such as CD9, CD63, and CD81. Characterization involves nanoparticle tracking analysis, electron microscopy, and Western blotting for exosomal markers. These methods are essential to quantify changes in exosome assembly upon genetic perturbation.
Proteomics and RNA profiling
Mass spectrometry-based proteomics can identify protein cargo and regulators of exosome assembly, as demonstrated by VEGFR2 proteomic studies in human placentas. RNA sequencing of exosomal RNA reveals cargo sorting mechanisms, such as miR-21 enrichment regulated by Snail. These approaches provide systems-level insights into exosome regulation.
Imaging of MVB and exosome trafficking
Fluorescence microscopy and live-cell imaging of fluorescently tagged ESCRT components or tetraspanins allow visualization of MVB dynamics and exosome release. CRISPR knock-in of tags facilitates tracking endogenous proteins. Correlative light and electron microscopy provides ultrastructural details of ILV formation.
Functional assays for exosome-mediated phenotypes
Exosomes can be transferred to recipient cells to assess functional outcomes, such as inflammasome suppression by miR-21 or drug resistance modulation by circRNA-CREIT. These assays link exosome assembly regulation to disease phenotypes and validate therapeutic targets.
How CRISPR Can Be Used to Study GO:1903551 regulation of extracellular exosome assembly
Knockout
CRISPR knockout of candidate genes such as Snail or CD151 allows researchers to determine their necessity in exosome assembly. For example, Snail knockout reduces exosomal miR-21 and enhances inflammasome activity, reversing cisplatin resistance. CD151 knockout impairs endolysosomal protein quality and promotes vascular inflammation. These models are invaluable for causal inference.
Point Mutation
CRISPR point mutation knock-in can mimic disease-associated variants or disrupt specific domains of exosome regulators. For instance, mutating phosphorylation sites in ESCRT components can reveal their role in MVB sorting. This approach provides precise mechanistic insights without altering protein levels.
Knock-in
CRISPR knock-in of fluorescent tags (e.g., GFP) or epitope tags into endogenous loci enables real-time tracking of exosome assembly proteins. Tagged CD63 or CD9 can be used to isolate exosomes and monitor their release. Knock-in of inducible promoters allows controlled overexpression for dose-response studies.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like circRNA-CREIT can test sufficiency in regulating exosome assembly. Overexpression of circRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance, demonstrating its regulatory role. Overexpression models complement knockout studies to establish causality.
How EDITGENE Supports regulation of extracellular exosome assembly Research
Researchers studying regulation of extracellular exosome assembly-related genes often need to determine whether a candidate gene is causally involved in vesicle biogenesis, cargo sorting, or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery process, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for regulation of extracellular exosome assembly research.
Frequently Asked Questions About regulation of extracellular exosome assembly
What is GO:1903551?
GO:1903551 is the Gene Ontology term for regulation of extracellular exosome assembly, defined as any process that modulates the frequency, rate or extent of extracellular vesicular exosome assembly.
What genes are involved in regulation of extracellular exosome assembly?
Key genes include Snail, VEGFR2, CD151, and ESCRT components, as well as non-coding RNAs like circRNA-CREIT.
How does Snail regulate exosome assembly?
Snail regulates the sorting of microRNA-21 into exosomes, which then suppress NLRP3 inflammasome activity and enhance cisplatin resistance.
What is the role of CD151 in exosome regulation?
CD151 maintains endolysosomal protein quality to inhibit vascular inflammation, influencing exosome assembly and trafficking.
Can exosome assembly be targeted for cancer therapy?
Yes, targeting regulators like Snail or circRNA-CREIT can overcome chemoresistance in cancers such as triple-negative breast cancer.
What methods are used to study exosome assembly?
Common methods include nanoparticle tracking analysis, Western blotting for tetraspanins, mass spectrometry, and CRISPR knockout screening.
How are CRISPR models used to study exosome assembly?
CRISPR knockout, knock-in, and overexpression models allow causal testing of genes in exosome biogenesis and cargo sorting.
What diseases are linked to dysregulated exosome assembly?
Diseases include cancer chemoresistance, vascular inflammation, polycystic kidney disease, and preeclampsia.
What is the clinical relevance of exosome assembly regulation?
It impacts drug resistance, immune modulation, and tissue repair, making it a promising therapeutic target.
How can EDITGENE help with exosome assembly research?
EDITGENE provides CRISPR knockout, knock-in, overexpression, and library screening services to study genes regulating exosome assembly.
Conclusion
Regulation of extracellular exosome assembly (GO:1903551) is a critical biological process that governs intercellular communication and influences diverse pathological states, from cancer chemoresistance to vascular inflammation and kidney disease. The integration of signaling pathways, ESCRT machinery, and cargo sorting ensures precise control of exosome biogenesis. Continued research using CRISPR-based models will uncover novel regulators and therapeutic opportunities. EDITGENE offers comprehensive services to support these discoveries.
References
- 1. Cheng HY et al.. 2022. Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance.. J Immunother Cancer 10(8) PMID: 36002186
- 2. Wang X et al.. 2022. CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.. J Hematol Oncol 15(1):122 PMID: 36038948
- 3. Ho SJ et al.. 2024. Proteomic studies of VEGFR2 in human placentas reveal protein associations with preeclampsia, diabetes, gravidity, and labor.. Cell Commun Signal 22(1):221 PMID: 38594674
- 4. Shen J et al.. 2025. Synergistic Wound Healing: Unraveling the Multi-Target Effects of Traditional Chinese Medicine and Its Biomaterials on Chronic Wound Pathways.. Int J Nanomedicine 20:12889-12912 PMID: 41158301
- 5. Chen J et al.. 2024. CD151 Maintains Endolysosomal Protein Quality to Inhibit Vascular Inflammation.. Circ Res 134(10):1330-1347 PMID: 38557119
- 6. Hogan MC et al.. 2024. An extracellular vesicle based hypothesis for the genesis of the polycystic kidney diseases.. Extracell Vesicle 4 PMID: 39886526
- 8. Meldolesi J. 2018. Exosomes and Ectosomes in Intercellular Communication.. Curr Biol 28(8):R435-R444 PMID: 29689228
